Aller au contenu

UCSF Department of Psychiatry and Behavioral Sciences

@ucsfpsych.bsky.social did:plc:td37ll5g4w6nscd22lclr3mt

We are committed to advancing mental health across the lifespan with a mission focused on research, teaching, patient care and public service. linktr.ee/ucsfpsychiatry Social Media Disclaimer: https://psychiatry.ucsf.edu/connect

Sur Bluesky depuis le

Abonnés
231
Abonnements
48
Posts
469
Jours dans les classements
0

Résumé

UCSF Department of Psychiatry and Behavioral Sciences (@ucsfpsych.bsky.social) est sur Bluesky depuis le 21 novembre 2024. Le compte a 231 abonnés, suit 48 comptes et a publié 469 posts.

Présence dans les classements

Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.

Ce compte n’est encore apparu dans aucun classement quotidien.

Posts aimés récemment

J’aime publics du réseau Bluesky.

  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in Pediatrics! Following 11,279 adolescents over 5 years, we found: 🔄 Problematic social media use & depression may reinforce each other 👧 The link was stronger among girls 🔗 tinyurl.com/DepSM26 @ameracadpeds.bsky.social

    Voir le post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    📱 What does the evidence show about policies to protect teens on social media? New in @jamanetworkopen.com: We reviewed 39 publications across 6 policy approaches. 🔗https://tinyurl.com/SMPolicy26

    Voir le post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in @ajpmonline.bsky.social! 🧠Adolescents in the low-to-moderate and moderate-to-high problematic social media use trajectories had lower cognitive performance 🔗 Read here: tinyurl.com/socmind @theabcdstudy.bsky.social

    Voir le post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in @annalsofepi.bsky.social! Among 10,735 adolescents in @theabcdstudy.bsky.social, we found that adolescents with increasing social media use are more likely to experience greater eating disorder symptoms. 🔗 Read here: tinyurl.com/EDTraj

    Voir le post
  • UCSF Edward and Pearl Fein Memory and Aging Center@ucsfmac.bsky.social

    Led by Adam Boxer, MD, PhD, and colleagues, UCSF is screening participants for the Alzheimer's Tau Platform (ATP) trial, the first large-scale national study to test combination therapy targeting both amyloid and tau in early or asymptomatic Alzheimer's disease.

    Voir le post

Connectez-vous pour en voir plus

Comptes bloqués

Sur Bluesky, les blocages sont publics.